Detail
| LncRNA Name | NORAD |
| Synonyms | NORAD, LINC00657, ASHGA5P032173 |
| Region | GRCh38_20:36045622-36050960 Sequence |
| Ensembl | ENSG00000260032 |
| RefSeq | NR_027451 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | pancreatic ductal adenocarcinoma |
| ICD-0-3 | C25.3 M8500/3 |
| Methods | microarray, qPCR, RNAi, Western blot etc. |
| Sample | PDAC tissues, cell lines (cell lines PANC1, Capan2, BXPC-3, Mia PaCa2, SW1990) |
| Expression Pattern | up-regulated |
| Function Description | The expression of Linc00675 in PDAC tissue samples was shown to be 672 times that in chronic pancreatitis tissue samples by microarray screening. This finding was confirmed in tumor tissues from 90 patients with PDAC compared with adjacent normal tissue samples by quantitative RT-PCR. We found that linc00675 overexpression positively correlated with lymph node metastasis, perineural invasion, and poor survival. |
| Pubmed ID | 26309360 |
| Year | 2015 |
| Title | Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma. |
| External Links |
| Links for NORAD | GenBank HGNC lncrnadb Noncode |
| Links for pancreatic ductal adenocarcinoma | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.